HRAS and neoplasm: First, all three samples showed ALK, APC, CSF1R, EGFR, FGFR1, FGFR3, FLT3, KDR, HRAS, PDGFRA, RET, and TP53 mutations with high frequency, which were considered indispensable for tumor progression in this SBA model.